10.1.1 We spoke to representatives of the following types of firms to develop this pricing study:
One CDMO in Europe
Three CDMOs in the United Kingdom
One CDMO in the United StatesOne pharma services company in Europe
Two innovators who are purchasing outsourced services and
One innovator who is manufacturing in-house large quantities of "Research Use Only" mRNA but does not manufacture GMP material.
Nice Insight provides customers with the latest trends in the market, hard-to-find pricing, and analysis of important scientific innovation and challenges. Our research reports help innovators understand the price they'll pay for a contractor and what challenges they should anticipate, and allow CDMOs to evaluate their position in the market.Nice Insight provides customers with the latest trends in the market, hard-to-find pricing, and analysis of important scientific innovation and challenges. Our research reports help innovators understand the price they'll pay for a contractor and what challenges they should anticipate, and allow CDMOs to evaluate their position in the market.